Shelton Capital Management Boosts Stake in Walgreens Boots Alliance Inc (WBA)

Shelton Capital Management grew its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 28.2% during the 4th quarter, Holdings Channel reports. The firm owned 158,857 shares of the pharmacy operator’s stock after purchasing an additional 34,956 shares during the period. Walgreens Boots Alliance accounts for about 0.7% of Shelton Capital Management’s portfolio, making the stock its 20th largest holding. Shelton Capital Management’s holdings in Walgreens Boots Alliance were worth $11,536,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the company. KBC Group NV grew its position in Walgreens Boots Alliance by 8.2% during the second quarter. KBC Group NV now owns 135,664 shares of the pharmacy operator’s stock worth $10,624,000 after buying an additional 10,267 shares in the last quarter. KDI Capital Partners LLC acquired a new stake in Walgreens Boots Alliance during the second quarter worth approximately $1,477,000. BB&T Securities LLC grew its position in Walgreens Boots Alliance by 13.0% during the second quarter. BB&T Securities LLC now owns 82,918 shares of the pharmacy operator’s stock worth $6,494,000 after buying an additional 9,528 shares in the last quarter. Jennison Associates LLC acquired a new stake in Walgreens Boots Alliance during the second quarter worth approximately $1,110,000. Finally, Annex Advisory Services LLC grew its position in Walgreens Boots Alliance by 39.9% during the second quarter. Annex Advisory Services LLC now owns 6,213 shares of the pharmacy operator’s stock worth $487,000 after buying an additional 1,772 shares in the last quarter. 61.24% of the stock is currently owned by institutional investors.

In other news, insider Stefano Pessina purchased 98,858 shares of the company’s stock in a transaction dated Monday, January 15th. The stock was bought at an average cost of $76.07 per share, for a total transaction of $7,520,128.06. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. 14.80% of the stock is currently owned by corporate insiders.

A number of equities research analysts recently issued reports on the company. Needham & Company LLC reissued a “buy” rating and set a $88.00 price target (up previously from $86.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, January 10th. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, January 10th. Loop Capital set a $90.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Thursday, October 26th. ValuEngine downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Finally, Robert W. Baird restated an “outperform” rating and set a $80.00 target price (down from $90.00) on shares of Walgreens Boots Alliance in a research note on Thursday, October 19th. They noted that the move was a valuation call. Eleven analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $85.53.

Shares of Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $68.46 on Monday. Walgreens Boots Alliance Inc has a 12 month low of $63.82 and a 12 month high of $88.00. The firm has a market capitalization of $67,820.00, a price-to-earnings ratio of 18.91, a price-to-earnings-growth ratio of 1.16 and a beta of 1.18. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.47 and a current ratio of 0.96.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, beating the Zacks’ consensus estimate of $1.27 by $0.01. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The company had revenue of $30.74 billion during the quarter, compared to analysts’ expectations of $30.39 billion. During the same period in the prior year, the company earned $1.10 EPS. Walgreens Boots Alliance’s revenue was up 7.9% compared to the same quarter last year. equities analysts anticipate that Walgreens Boots Alliance Inc will post 5.71 EPS for the current fiscal year.

Walgreens Boots Alliance declared that its Board of Directors has approved a share buyback plan on Wednesday, October 25th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the pharmacy operator to purchase shares of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board believes its shares are undervalued.

The company also recently declared a quarterly dividend, which will be paid on Monday, March 12th. Stockholders of record on Thursday, February 15th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.34%. The ex-dividend date of this dividend is Wednesday, February 14th. Walgreens Boots Alliance’s payout ratio is 44.20%.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at https://www.com-unik.info/2018/02/12/shelton-capital-management-boosts-stake-in-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit